OTLKW

Outlook Therapeutics, Inc. - Se$0.03

%

Analyst Rating:N/A

Analyst Rating: N/A

Stock Details

CEO

None

Sector

Healthcare

Industry

Biotechnology

Full Time Employees

0

Address

DE

No description available.

Income Statement

Revenue

Net Income

Financials

Selected Year

Revenue Estimates

EPS Estimates

Net Income Estimates

Price target for Outlook Therapeutics, Inc. - Se $0.03

EPS

Revenue

Congress Tracker

Insider Trading of Key Employees

Financial News: OTLKW